Venetoclax plus hypomethylating agent for the salvage treatment of relapsing myeloid malignancies after hematopoietic stem cell transplantation: A multicenter retrospective study on behalf of the Zhejiang Cooperative Group for Blood and Marrow Transplantation.
Fei GaoYang GaoYi LuoJian YuHuarui FuXiaoyu LaiLizhen LiuBaodong YeJianping LanXiaolu SongYing LuLieguang ChenYi ChenKang YuHe HuangJimin ShiYanmin ZhaoPublished in: American journal of hematology (2021)